hVIVO plc (AIM:HVO)
London · Delayed Price · Currency is GBP · Price in GBX 7.50
+0.80 (11.94%)
Jul 24, 2026, 4:35 PM GMT
hVIVO Revenue
In the year 2025, hVIVO had annual revenue of 46.77M GBP, down -25.43%. hVIVO had revenue of 22.58M in the half year ending December 31, 2025, a decrease of -21.44%.
Revenue
46.77M
Revenue Growth
-25.43%
P/S Ratio
1.04
Revenue / Employee
132.07K
Employees
376
Market Cap
51.53M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 46.77M | -15.95M | -25.43% |
| Dec 31, 2024 | 62.73M | 6.68M | 11.92% |
| Dec 31, 2023 | 56.04M | 7.57M | 15.61% |
| Dec 31, 2022 | 48.48M | 11.61M | 31.50% |
| Dec 31, 2021 | 36.86M | 16.26M | 78.93% |
| Dec 31, 2020 | 20.60M | 17.23M | 510.97% |
| Dec 31, 2019 | 3.37M | -7.65M | -69.41% |
| Dec 31, 2018 | 11.03M | 147.00K | 1.35% |
| Dec 31, 2017 | 10.88M | -4.39M | -28.75% |
| Dec 31, 2016 | 15.27M | 7.55M | 97.85% |
| Dec 31, 2015 | 7.72M | -10.76M | -58.22% |
| Dec 31, 2014 | 18.47M | 16.78M | 993.17% |
| Dec 31, 2013 | 1.69M | -489.64K | -22.47% |
| Dec 31, 2012 | 2.18M | -689.38K | -24.03% |
| Dec 31, 2011 | 2.87M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bioventix | 12.54M |
| SkinBioTherapeutics | 5.23M |
| Scancell Holdings | 4.71M |
| Arecor Therapeutics | 1.71M |
| 4basebio | 1.69M |
| Ondine Biomedical | 1.43M |
| Faron Pharmaceuticals Oy | 1.14M |
| ImmuPharma | -69.96K |
hVIVO News
- 3 days ago - hVIVO Earnings release: H1 2026 - Filings
- 6 weeks ago - hVIVO Transcript: CMD 2026 - Transcripts
- 6 weeks ago - hVIVO Slides: FY 2026 - Filings
- 7 weeks ago - Decoy Therapeutics Partners With HVIVO To Advance D-MAV Into Clinical Study; Stock Up - Nasdaq
- 3 months ago - Full Year 2025 hVIVO PLC Earnings Presentation Transcript - GuruFocus
- 3 months ago - hVIVO Earnings Call Transcript: H2 2025 - Transcripts
- 3 months ago - hVIVO Annual report: H2 2025 - Filings
- 3 months ago - hVIVO Slides: H2 2025 - Filings